The goal of this clinical trial is to learn if inverted-Ω anastomosis after pancreatic head resection or mid-pancreatectomy works in benign or low-grade malignant tumor. It will also learn about the safety and feasibility of inverted-Ω anastomosis. The main questions it aims to answer are: 1. Does inverted-Ω anastomosis operate safely? (operative time, blood loss, transfusion and conversion rate) 2. What is the incidence and severity of postoperative complications in inverted -Ω anastomosis? What advantages does it have over conventional anastomosis methods such as roux-en-y?
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
After meeting the inclusion and exclusion criteria, duodenum-preserving pancreatic head resection or mid-pancreatic resection will be performed, and inverted-Ω anastomosis will be carried out during the operation for the reconstruction of the digestive tract
West China Hospital
Chengdu, Sichuan, China
Safety and assessment of the surgical process
The incidence of intraoperative adverse events such as conversion to open surgery rate
Time frame: During operation
Operative time
Operative time
Time frame: During operation
Intraoperative blood loss
Intraoperative blood loss
Time frame: During operation
Postoperative complications
The incidence and severity of postoperative complications, as defined by the International Study Group on Pancreatic Surgery (ISGPS)
Time frame: From the date of surgery (Day 0) up to 90 days postoperatively
Short-term survival
Time frame: From the date of surgery (Day 0) up to 3 years postoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.